SLC29A3 as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma

被引：1
|
作者：
Ma, Guorong [1 ,2 ]
Rong, Yao [1 ,3 ]
Liu, Song -Hua [1 ,3 ]
Guo, Hongzhang [4 ,5 ]
机构：
[1] Gansu Univ Chinese Med, Gansu Prov Hosp, Clin Med Coll 1, Lanzhou, Peoples R China
[2] Chinese Acad Sci, Inst Modern Phys, Lanzhou 730000, Peoples R China
[3] Gansu Prov Hosp, Key Lab Mol Diagnost & Precis Med Surg Oncol Gansu, Lanzhou, Gansu, Peoples R China
[4] Gansu Prov Hosp, Lanzhou 730000, Peoples R China
[5] 204 Donggang West Rd, Lanzhou, Gansu, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2024年 / 47卷 / 04期
关键词：
D O I：
10.1016/j.asjsur.2023.12.172
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：1936 / 1938
页数：3
相关论文
共 50 条
  • [1] Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
    Ma, Jiaxiu
    Jin, Jiapei
    Lu, Huishuang
    Zhang, Jin
    Li, Yalan
    Cai, Xuefei
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [2] CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
    Tang, Kaihua
    Li, Xiaoting
    Mo, Jianwen
    Chen, Yixuan
    Huang, Chengyu
    Li, Ting
    Luo, Tianjian
    Zhong, Zhijian
    Jiang, Yongqiang
    Yang, Dengfeng
    Mo, Weiliang
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [3] CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
    Kaihua Tang
    Xiaoting Li
    Jianwen Mo
    Yixuan Chen
    Chengyu Huang
    Ting Li
    Tianjian Luo
    Zhijian Zhong
    Yongqiang Jiang
    Dengfeng Yang
    Weiliang Mo
    [J]. Scientific Reports, 13
  • [4] APOB is a potential prognostic biomarker in hepatocellular carcinoma
    Zhifeng Lin
    Xiaohui Ji
    Nana Tian
    Yu Gan
    Li Ke
    [J]. Discover Oncology, 15
  • [5] Fidgetin as a potential prognostic biomarker for hepatocellular carcinoma
    Zhou, Bin
    Wang, Jisheng
    Gao, Jing
    Xie, Junqing
    Chen, Yiming
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (17): : 2888 - 2894
  • [6] APOB is a potential prognostic biomarker in hepatocellular carcinoma
    Lin, Zhifeng
    Ji, Xiaohui
    Tian, Nana
    Gan, Yu
    Ke, Li
    [J]. DISCOVER ONCOLOGY, 2024, 15 (01)
  • [7] Auto Inflammatory Syndrome with SLC29A3 Mutation
    Jain, Abhishek
    Maheshwari, Anu
    Mahto, Deonath
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2024, 91 (03): : 314 - 314
  • [8] NRAGE is a potential diagnostic biomarker of hepatocellular carcinoma
    Zou, Wenshuang
    Cui, Junfeng
    Ren, Zhong
    Leng, Yan
    [J]. MEDICINE, 2018, 97 (48)
  • [9] Expanding the clinical spectrum of SLC29A3 gene defects
    Spiegel, Ronen
    Cliffe, Simon T.
    Buckley, Michael F.
    Crow, Yanick J.
    Urquhart, Jill
    Horovitz, Yoseph
    Tenenbaum-Rakover, Yardena
    Newman, William G.
    Donnai, Dian
    Shalev, Stavit A.
    [J]. EUROPEAN JOURNAL OF MEDICAL GENETICS, 2010, 53 (05) : 309 - 313
  • [10] Acetylcarnitine Is a Candidate Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma
    Lu, Yonghai
    Li, Ning
    Gao, Liang
    Xu, Yong-Jiang
    Huang, Chong
    Yu, Kangkang
    Ling, Qingxia
    Cheng, Qi
    Chen, Shengsen
    Zhu, Mengqi
    Fang, Jinling
    Chen, Mingquan
    Ong, Choon Nam
    [J]. CANCER RESEARCH, 2016, 76 (10) : 2912 - 2920
12345